Anti-RIL antibody [EPR16199]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal RIL antibody. Suitable for WB and reacts with Human samples. Cited in 1 publication.
View Alternative Names
RIL, PDLIM4, PDZ and LIM domain protein 4, LIM protein RIL, Reversion-induced LIM protein
- WB
Supplier Data
Western blot - Anti-RIL antibody [EPR16199] (AB197026)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-RIL antibody [EPR16199] (ab197026) at 1/10000 dilution
All lanes:
SH-SY5Y (Human neuroblastoma from bone marrow cells) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 35 kDa
Observed band size: 35 kDa
false
- WB
Supplier Data
Western blot - Anti-RIL antibody [EPR16199] (AB197026)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-RIL antibody [EPR16199] (ab197026) at 1/1000 dilution
All lanes:
PC-3 (Human prostate cancer cell line) whole cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 35 kDa
Observed band size: 35 kDa
false
- WB
Supplier Data
Western blot - Anti-RIL antibody [EPR16199] (AB197026)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-RIL antibody [EPR16199] (ab197026) at 1/1000 dilution
All lanes:
A431 (Human epidermoid carcinoma) whole cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 35 kDa
Observed band size: 35 kDa
false
Related conjugates and formulations (1)
-
Anti-RIL antibody [EPR16199] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
RIL has a role in maintaining cellular structure and dynamics. It participates in cytoskeletal organization helping stabilize actin filaments within cells. RIL associates with other LIM domain proteins to form complexes that integrate signals directed to the cytoskeleton contributing to cellular integrity and response to environmental cues. It also interacts with alpha-actinin and other cytoskeletal-associated proteins supporting cellular morphology and motility.
Pathways
The protein supports cellular architecture and signaling. It plays roles in the actin cytoskeleton regulatory pathway and the focal adhesion pathway. RIL works alongside proteins such as alpha-actinin and integrins to ensure proper signal transduction and cellular structural organization. Its interaction within these pathways helps in transmitting mechanical and chemical signals essential for cellular responses and adaptations.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Cell biochemistry and function 35:144-155 PubMed28370438
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com